Related Experiment Video
Updated: Aug 17, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Glycemic control and cardiovascular disease in type 2 diabetes: a review
S H Wild1, C J Dunn, P M McKeigue
1Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. Sarah.Wild@nwanglia.anglox.nhs.uk
Insights
People with Type 2 diabetes face high cardiovascular disease risks. Managing hypertension and hyperlipidemia is crucial for reducing this risk, potentially more effectively than solely focusing on glycemic control.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Diseases
Background:
- Type 2 diabetes significantly elevates cardiovascular disease (CVD) risk, including atherosclerotic disease.
- This increased risk in diabetic patients surpasses that explained by common comorbidities like hypertension and hyperlipidemia.
Purpose of the Study:
- To review the impact of hyperglycemia and glycemic control on CVD in Type 2 diabetes.
- To synthesize findings from prospective observational studies and randomized controlled trials.
Main Methods:
- Systematic review of existing literature.
- Analysis of prospective observational studies.
- Evaluation of randomized controlled trials (RCTs).
Main Results:
- Elevated blood glucose levels (hyperglycemia) play a role in CVD development in Type 2 diabetes.
- Effective management of hypertension and hyperlipidemia is vital for CVD risk reduction.
- Achieving tight glycemic control may be more challenging than managing other cardiovascular risk factors.
Conclusions:
- Controlling hypertension and hyperlipidemia are key strategies to mitigate CVD risk in individuals with Type 2 diabetes.
- These interventions may offer a more attainable approach to risk reduction compared to stringent glycemic control alone.
Abstract:
Cardiovascular disease is the major cause of morbidity and mortality in people with Type 2 diabetes, and risk of atherosclerotic disease is markedly increased in people with diabetes compared to people with normal glucose tolerance. The excess risk can not be completely explained by increased prevalence of other cardiovascular disease risk factors such as hypertension and hyperlipidaemia in people with diabetes. This review examines the role of hyperglycemia and glycemic control in cardiovascular disease in people with Type 2 diabetes. The results of prospective observational studies and randomized controlled trials are summarized. We conclude that control of hypertension and hyperlipidemia are important to reduce risk of cardiovascular disease in people with diabetes and may be more easily achieved than tight glycemic control.
More Related Videos
Related Concept Videos
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

